Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-26

Clinical Trial Update: Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update showing long-term efficacy and safety of HMS5552 added to metformin in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMS5552

Snippet

Sponsor: Hua Medicine Limited | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED